Who owns PAVMED INC COM?

Tip: Access positions for across all investors

Analyze quarterly positions in Pavmed with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Pavmed stock

Who bought or sold PAVMED INC COM this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Two Seas Capital 462k $1.7M 0% Sep 2026
 View chart
First Manhattan 333k $2.0M 1298% Jun 2026
 View chart
Vanguard Capital Management 62k $366k 941% Jun 2026
 View chart
Geode Capital Management 30k $109k -20% Sep 2026
 View chart
Vanguard Fiduciary Trust 26k $152k 372% Jun 2026
 View chart
BlackRock 17k $102k 607% Jun 2026
 View chart
Parkside Financial Bank & Trust 246.00 $907.002000 100% Sep 2026
 View chart
SBI Securities 67.00 $247.002200 0% Sep 2026
 View chart
UBS Group 57.00 $338.363400 -24% Jun 2026
 View chart
Wells Fargo & Company 45.00 $266.998500 0% Jun 2026
 View chart
Citigroup 9.00 $33.000300 100% Sep 2026
 View chart
Hanson McClain Advisors 6.00 $36.000000 20% Sep 2026
 View chart
Advisor Group Holdings 4.00 $21.000000 0% Jun 2026
 View chart
Federation des caisses Desjardins du Quebec 4.00 $23.000000 100% Jun 2026
 View chart
BFC Planning 2.00 $12.000000 100% Jun 2026
 View chart
Steward Partners Investment Advisory 2.00 $12.000000 100% Jun 2026
 View chart
Caitong International Asset Management 1.00 $4.000000 0% Sep 2026
 View chart
Foresight Capital Management Advisors 1.00 $4.000000 100% Sep 2026
 View chart
Royal Bank of Canada 1.00 $0 100% Jun 2026
 View chart
Jones Financial Companies, L.L 1.00 $5.000000 0% Jun 2026
 View chart
Bnp Paribas Arbitrage, Snc 1.00 $6.000000 0% Jun 2026
 View chart

Who sold out of Pavmed?

Fund or Company Name Date Sold Shares Held Valued At
Tower Research Capital Mar 2026 622.00 $6.3k
Barclays Jun 2026 75.00 $446.002500
Vanguard Global Advisers Mar 2026 61.00 $618.997500
Group One Trading Mar 2026 2.00 $20.000000